Numerous investigations have demonstrated significant and long-lasting neurological
manifestations of COVID-19. It has been suggested that as many as four out of five patients …

Background The COVID-19 pandemic has been an inciting factor for a wide variety of
neuropsychiatric symptoms, including first-episode psychosis. Objective: The aim of this …

Background and purpose Psychiatric disorders such as anxiety, depression, and traumatic
stress are not rare during infectious outbreaks, as the COVID-19 pandemic has posed a …

SARS-CoV-2 induces illness and death in humans by causing systemic infections. Evidence
suggests that SARS-CoV-2 can induce brain pathology in humans and other hosts. In this …

Early detection is crucial to mitigate the impact of emerging threats. This work proposes four
innovative frameworks that build machine learning and deterministic epidemiological …

Background Neurological manifestations in patients with COVID-19 have been reported
previously as outcomes of the infection. The purpose of current study was to investigate the …

A growing number of scientific contributions suggest that COVID-19 infection can lead to
impairment of cognition, mainly in executive functions and memory domains, even in the …

Background Increasing reports of manic episodes in patients during acute infection with
COVID-19 have been documented since the pandemic began, including individuals without …

Background: Vaccination for coronavirus disease 2019 (COVID-19) has demonstrated
reduced risk of hospitalisation and death against more recent variants of COVID-19. Some …

Long COVID has been studied as different sequelae that some individuals can develop after
the acute phase of the disease. Persistent symptoms such as dry cough, fatigue, and …